Inspire Medical Systems Inc
NYSE:INSP
Inspire Medical Systems Inc
NYSE:INSP
Price:
154.525 USD
-2.83%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Inspire Medical Systems Inc
Inspire Medical Systems Inc
| Current Assets | 572.2m |
| Cash & Short-Term Investments | 441.4m |
| Receivables | 72.3m |
| Other Current Assets | 58.5m |
| Non-Current Assets | 113.6m |
| Long-Term Investments | 27.8m |
| PP&E | 74.5m |
| Other Non-Current Assets | 11.3m |
| Current Liabilities | 72.2m |
| Accounts Payable | 43.8m |
| Accrued Liabilities | 28.4m |
| Non-Current Liabilities | 24.6m |
| Other Non-Current Liabilities | 24.6m |
Balance Sheet
Inspire Medical Systems Inc
Inspire Medical Systems Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
7
|
9
|
97
|
23
|
191
|
215
|
442
|
186
|
|
| Cash Equivalents |
7
|
9
|
97
|
23
|
191
|
215
|
442
|
186
|
|
| Short-Term Investments |
0
|
7
|
91
|
127
|
44
|
0
|
10
|
275
|
|
| Total Receivables |
2
|
4
|
7
|
13
|
25
|
34
|
61
|
90
|
|
| Accounts Receivables |
2
|
4
|
7
|
13
|
25
|
34
|
61
|
90
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
4
|
3
|
6
|
9
|
17
|
12
|
34
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
2
|
3
|
6
|
10
|
|
| Total Current Assets |
12
|
24
|
199
|
171
|
270
|
269
|
530
|
594
|
|
| PP&E Net |
1
|
1
|
1
|
4
|
11
|
16
|
24
|
63
|
|
| PP&E Gross |
1
|
1
|
1
|
4
|
11
|
16
|
24
|
63
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
2
|
3
|
5
|
7
|
|
| Long-Term Investments |
0
|
0
|
0
|
6
|
0
|
10
|
0
|
9
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
11
|
11
|
|
| Total Assets |
13
N/A
|
25
+92%
|
200
+697%
|
181
-9%
|
281
+55%
|
295
+5%
|
565
+91%
|
677
+20%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
3
|
5
|
7
|
12
|
27
|
39
|
|
| Accrued Liabilities |
3
|
4
|
8
|
12
|
14
|
21
|
34
|
39
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
|
| Total Current Liabilities |
7
|
7
|
11
|
17
|
21
|
41
|
61
|
78
|
|
| Long-Term Debt |
12
|
17
|
25
|
25
|
25
|
16
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
6
|
9
|
8
|
26
|
|
| Total Liabilities |
20
N/A
|
24
+21%
|
36
+52%
|
41
+15%
|
51
+24%
|
66
+28%
|
69
+4%
|
104
+51%
|
|
| Equity | |||||||||
| Common Stock |
94
|
119
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
108
|
125
|
147
|
180
|
237
|
279
|
324
|
345
|
|
| Additional Paid In Capital |
7
|
7
|
311
|
320
|
467
|
509
|
820
|
917
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
7
N/A
|
1
N/A
|
164
+12 515%
|
140
-15%
|
230
+64%
|
229
0%
|
496
+117%
|
573
+15%
|
|
| Total Liabilities & Equity |
13
N/A
|
25
+92%
|
200
+697%
|
181
-9%
|
281
+55%
|
295
+5%
|
565
+91%
|
677
+20%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
20
|
20
|
23
|
24
|
27
|
27
|
29
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
